MedTrace Logo

Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-

NCT04843813 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-04-15

No results posted yet for this study

Summary

The central hypothesis is that lutein supplementation will improve MPOD and cognition. Accordingly, the specific aims are to 1) to determine the process feasibility associated with participating in 4-month lutein supplementation trial; and 2) to investigate the scientific feasibility of 4-month daily lutein supplementation on biological markers of lutein status and cognitive function among persons with MS.

Conditions

Interventions

DIETARY_SUPPLEMENT

Lutein

Participants will consume daily soft gels containing the lutein supplement.

DIETARY_SUPPLEMENT

Placebo

Participants will consume daily soft gels containing the safflower oil.

Sponsors & Collaborators

  • Division of Nutritional Sciences, University of Illinois at Urbana-Champaign

    collaborator UNKNOWN

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Illinois at Urbana-Champaign

    lead OTHER

Principal Investigators

  • Naiman Khan, PhD · University of Illinois Urbana Champaign

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-26
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04843813 on ClinicalTrials.gov